Back to News
Market Impact: 0.25

House passes spending bill to avert another government shutdown

Fiscal Policy & BudgetRegulation & LegislationElections & Domestic Politics
House passes spending bill to avert another government shutdown

On Jan. 8 the House approved a bipartisan appropriations package by a 397-28 vote to avert another government shutdown, sending the funding bill to the Senate which has until Jan. 30 (including a weeklong recess) to act. Large portions of the government are already funded for the fiscal year, meaning any lapse would likely be partial; the measure reduces near-term fiscal tail risk for markets, though ongoing negotiations over rising health-care costs leave some policy uncertainty.

Analysis

Market structure: Passing a House funding package reduces the short-term binary risk of a full federal shutdown ahead of the Jan 30 Senate deadline, favoring government contractors, defense (Lockheed LMT, Northrop NOC), and travel/leisure firms that suffer most from furlough-driven demand shocks. Partial shutdown risk remains, so expect uneven winners: contractors with FY funding already secured gain pricing power while small-cap consumer names and discretionary services remain vulnerable to payment delays. Cross-asset: averted shutdown should remove a modest flight-to-quality bid—expect 5–15bp higher front-end Treasury yields, modest USD softness, and 10–30% compression in 30-day equity implied vol relative to a shutdown scenario.

Risk assessment: Tail risks include Senate failure to pass the bill (low-probability before Jan 30 but >0) that could cause a two-week partial shutdown shaving ~0.1–0.3% off Q1 GDP and spiking counterparty liquidity strains for small government vendors. Immediate window (days): headline-driven volatility into Senate vote; short-term (weeks): sector rotations as health-care cost negotiations evolve; long-term (quarters): budget fights could reappear into FY26 planning. Hidden dependency: healthcare negotiations could trigger regulatory or reimbursement changes that materially affect insurers and large-cap pharma margins beyond the funding mechanics.

Trade implications: Tactical longs in defense/aerospace (ITA or LMT) and travel/leisure (DAL, LUV) for 1–3 months are favored if Senate passes; hedge directionally with short-dated equity puts through Jan 30 to cap headline risk. Rates: reduce net duration by ~0.5–1 year and consider short 2y futures sized to 0.5% NAV targeting a 10–25bp 2y yield pickup; options: sell short-dated SPX straddles only after IV collapses >20% post-passage. Entry: scale into positions now, trim/flip if Senate stalls past Jan 30 or if implied vol breaches +50% from current levels.

More News